Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deng-Fu Yao

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
World Journal of Gastroenterology|November 10, 2012
Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinomaHai-Jian Zhang, Deng-Fu Yao, Min Yao, et al.
World Journal of Gastrointestinal Oncology|June 9, 2025
Up-regulated programmed cell death protein-1/its ligand 1 expression promotes metabolic dysfunction-associated steatotic liver disease malignant progressionMin Xu, Tian-Tian Ruan, Hao Tang, et al.
World Journal of Clinical Cases|October 17, 2022
Effects of targeted-edited oncogenic insulin-like growth factor-1 receptor with specific-sgRNA on biological behaviors of HepG2 cellsMin Yao, Yin Cai, Zhi-Jun Wu, et al.
World Journal of Gastroenterology|January 28, 2017
Mitochondrial carnitine palmitoyl transferase-II inactivity aggravates lipid accumulation in rat hepatocarcinogenesisJuan-Juan Gu, Min Yao, Jie Yang, et al.
World Journal of Gastroenterology|June 24, 2021
Oncogenic tuftelin 1 as a potential molecular-targeted for inhibiting hepatocellular carcinoma growthMeng-Na Wu, Wen-Jie Zheng, Wen-Xin Ye, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|May 1, 2018
Expression of hepatic Wnt5a and its clinicopathological features in patients with hepatocellular carcinomaLi Wang, Min Yao, Miao Fang, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|September 13, 2013
[Effects of inhibited IGF-IR expression on proliferation and apoptosis of human hepatocellular carcinoma cell lines]Ning-hua Yao, Deng-fu Yao, Zhi-zhen Dong, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 17, 2006
Abnormal expression of HSP gp96 associated with HBV replication in human hepatocellular carcinomaDeng-Fu Yao, Xin-Hua Wu, Xiao-Qin Su, et al.
Zhonghua Yi Xue Za Zhi|July 19, 2013
[Abnormal expression of insulin-like growth factor-II and intervening of its mRNA transcription in the promotion of HepG2 cell apoptosis]Zhi-zhen Dong, Min Yao, Jing Qian, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|November 26, 2022
Oncogenic Wnt3a is a promising sensitive biomarker for monitoring hepatocarcinogenesisMin Yao, Jian-Jun Wang, Xi-Yu Chen, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
World Journal of Gastroenterology|November 10, 2012
Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinomaHai-Jian Zhang, Deng-Fu Yao, Min Yao, et al.
World Journal of Gastrointestinal Oncology|June 9, 2025
Up-regulated programmed cell death protein-1/its ligand 1 expression promotes metabolic dysfunction-associated steatotic liver disease malignant progressionMin Xu, Tian-Tian Ruan, Hao Tang, et al.
World Journal of Clinical Cases|October 17, 2022
Effects of targeted-edited oncogenic insulin-like growth factor-1 receptor with specific-sgRNA on biological behaviors of HepG2 cellsMin Yao, Yin Cai, Zhi-Jun Wu, et al.
World Journal of Gastroenterology|January 28, 2017
Mitochondrial carnitine palmitoyl transferase-II inactivity aggravates lipid accumulation in rat hepatocarcinogenesisJuan-Juan Gu, Min Yao, Jie Yang, et al.
World Journal of Gastroenterology|June 24, 2021
Oncogenic tuftelin 1 as a potential molecular-targeted for inhibiting hepatocellular carcinoma growthMeng-Na Wu, Wen-Jie Zheng, Wen-Xin Ye, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|May 1, 2018
Expression of hepatic Wnt5a and its clinicopathological features in patients with hepatocellular carcinomaLi Wang, Min Yao, Miao Fang, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|September 13, 2013
[Effects of inhibited IGF-IR expression on proliferation and apoptosis of human hepatocellular carcinoma cell lines]Ning-hua Yao, Deng-fu Yao, Zhi-zhen Dong, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 17, 2006
Abnormal expression of HSP gp96 associated with HBV replication in human hepatocellular carcinomaDeng-Fu Yao, Xin-Hua Wu, Xiao-Qin Su, et al.
Zhonghua Yi Xue Za Zhi|July 19, 2013
[Abnormal expression of insulin-like growth factor-II and intervening of its mRNA transcription in the promotion of HepG2 cell apoptosis]Zhi-zhen Dong, Min Yao, Jing Qian, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|November 26, 2022
Oncogenic Wnt3a is a promising sensitive biomarker for monitoring hepatocarcinogenesisMin Yao, Jian-Jun Wang, Xi-Yu Chen, et al.
Pageof 6